178 related articles for article (PubMed ID: 36999536)
1. Membrane phospholipid remodeling modulates nonalcoholic steatohepatitis progression by regulating mitochondrial homeostasis.
Tian Y; Jellinek MJ; Mehta K; Seok SM; Kuo SH; Lu W; Shi R; Lee R; Lau GW; Kemper JK; Zhang K; Ford DA; Wang B
Hepatology; 2024 Apr; 79(4):882-897. PubMed ID: 36999536
[TBL] [Abstract][Full Text] [Related]
2. Caspase-independent hepatocyte death: A result of the decrease of lysophosphatidylcholine acyltransferase 3 in non-alcoholic steatohepatitis.
Kakisaka K; Suzuki Y; Fujiwara Y; Suzuki A; Kanazawa J; Takikawa Y
J Gastroenterol Hepatol; 2019 Jul; 34(7):1256-1262. PubMed ID: 30160786
[TBL] [Abstract][Full Text] [Related]
3. Research progress, challenges and perspectives of phospholipids metabolism in the LXR‑LPCAT3 signaling pathway and its relation to NAFLD (Review).
Wang J; Li J; Fu Y; Zhu Y; Lin L; Li Y
Int J Mol Med; 2024 Apr; 53(4):. PubMed ID: 38362962
[TBL] [Abstract][Full Text] [Related]
4. Deficiency in lysophosphatidylcholine acyltransferase 3 reduces plasma levels of lipids by reducing lipid absorption in mice.
Li Z; Jiang H; Ding T; Lou C; Bui HH; Kuo MS; Jiang XC
Gastroenterology; 2015 Nov; 149(6):1519-29. PubMed ID: 26226572
[TBL] [Abstract][Full Text] [Related]
5. Lipidomic and transcriptomic analysis of western diet-induced nonalcoholic steatohepatitis (NASH) in female Ldlr -/- mice.
Garcia-Jaramillo M; Spooner MH; Löhr CV; Wong CP; Zhang W; Jump DB
PLoS One; 2019; 14(4):e0214387. PubMed ID: 30943218
[TBL] [Abstract][Full Text] [Related]
6. LC-MS-based lipidomic analysis in distinguishing patients with nonalcoholic steatohepatitis from nonalcoholic fatty liver.
Wang ZH; Zheng KI; Wang XD; Qiao J; Li YY; Zhang L; Zheng MH; Wu J
Hepatobiliary Pancreat Dis Int; 2021 Oct; 20(5):452-459. PubMed ID: 34256994
[TBL] [Abstract][Full Text] [Related]
7. HILPDA promotes NASH-driven HCC development by restraining intracellular fatty acid flux in hypoxia.
Povero D; Chen Y; Johnson SM; McMahon CE; Pan M; Bao H; Petterson XT; Blake E; Lauer KP; O'Brien DR; Yu Y; Graham RP; Taner T; Han X; Razidlo GL; Liu J
J Hepatol; 2023 Aug; 79(2):378-393. PubMed ID: 37061197
[TBL] [Abstract][Full Text] [Related]
8. LPCAT3/LPLAT12 deficiency in the liver ameliorates acetaminophen-induced acute liver injury.
Inagaki NF; Nakanishi H; Ohto T; Shindou H; Shimizu T
FASEB J; 2024 Jan; 38(1):e23328. PubMed ID: 38019192
[TBL] [Abstract][Full Text] [Related]
9. Inhibiting Phosphatidylcholine Remodeling in Adipose Tissue Increases Insulin Sensitivity.
He M; Li Z; Tung VSK; Pan M; Han X; Evgrafov O; Jiang XC
Diabetes; 2023 Nov; 72(11):1547-1559. PubMed ID: 37625119
[TBL] [Abstract][Full Text] [Related]
10. Hepatic Phospholipid Remodeling Modulates Insulin Sensitivity and Systemic Metabolism.
Tian Y; Mehta K; Jellinek MJ; Sun H; Lu W; Shi R; Ingram K; Friedline RH; Kim JK; Kemper JK; Ford DA; Zhang K; Wang B
Adv Sci (Weinh); 2023 Jun; 10(18):e2300416. PubMed ID: 37088778
[TBL] [Abstract][Full Text] [Related]
11. Lack of VMP1 impairs hepatic lipoprotein secretion and promotes non-alcoholic steatohepatitis.
Jiang X; Fulte S; Deng F; Chen S; Xie Y; Chao X; He XC; Zhang Y; Li T; Li F; McCoin C; Morris EM; Thyfault J; Liu W; Li L; Davidson NO; Ding WX; Ni HM
J Hepatol; 2022 Sep; 77(3):619-631. PubMed ID: 35452693
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-223 Ameliorates Nonalcoholic Steatohepatitis and Cancer by Targeting Multiple Inflammatory and Oncogenic Genes in Hepatocytes.
He Y; Hwang S; Cai Y; Kim SJ; Xu M; Yang D; Guillot A; Feng D; Seo W; Hou X; Gao B
Hepatology; 2019 Oct; 70(4):1150-1167. PubMed ID: 30964207
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological inhibition of CFTR attenuates nonalcoholic steatohepatitis (NASH) progression in mice.
Rajak S; Tewari A; Raza S; Gupta P; Chakravarti B; Anjum B; Tripathi M; Singh BK; Yen PM; Goel A; Ghosh S; Sinha RA
Biochim Biophys Acta Mol Basis Dis; 2023 Apr; 1869(4):166662. PubMed ID: 36754244
[TBL] [Abstract][Full Text] [Related]
14. Lpcat3 deficiency promotes palmitic acid-induced 3T3-L1 mature adipocyte inflammation through enhanced ROS generation.
Hu J; Deng Y; Ding T; Dong J; Liang Y; Lou B
Acta Biochim Biophys Sin (Shanghai); 2022 Nov; 55(1):117-130. PubMed ID: 36331295
[TBL] [Abstract][Full Text] [Related]
15. Inhibiting SCAP/SREBP exacerbates liver injury and carcinogenesis in murine nonalcoholic steatohepatitis.
Kawamura S; Matsushita Y; Kurosaki S; Tange M; Fujiwara N; Hayata Y; Hayakawa Y; Suzuki N; Hata M; Tsuboi M; Kishikawa T; Kinoshita H; Nakatsuka T; Sato M; Kudo Y; Hoshida Y; Umemura A; Eguchi A; Ikenoue T; Hirata Y; Uesugi M; Tateishi R; Tateishi K; Fujishiro M; Koike K; Nakagawa H
J Clin Invest; 2022 Jun; 132(11):. PubMed ID: 35380992
[TBL] [Abstract][Full Text] [Related]
16. Identification of Hepatic Lysophosphatidylcholine Acyltransferase 3 as a Novel Target Gene Regulated by Peroxisome Proliferator-activated Receptor δ.
Singh AB; Liu J
J Biol Chem; 2017 Jan; 292(3):884-897. PubMed ID: 27913621
[TBL] [Abstract][Full Text] [Related]
17. Deletion of lysophosphatidylcholine acyltransferase 3 in myeloid cells worsens hepatic steatosis after a high-fat diet.
Bourgeois T; Jalil A; Thomas C; Magnani C; Le Guern N; Gautier T; Pais de Barros JP; Bergas V; Choubley H; Mazzeo L; Menegaut L; Josiane Lebrun L; Van Dongen K; Xolin M; Jourdan T; Buch C; Labbé J; Saas P; Lagrost L; Masson D; Grober J
J Lipid Res; 2021; 62():100013. PubMed ID: 33518513
[TBL] [Abstract][Full Text] [Related]
18. Lpcat3-dependent production of arachidonoyl phospholipids is a key determinant of triglyceride secretion.
Rong X; Wang B; Dunham MM; Hedde PN; Wong JS; Gratton E; Young SG; Ford DA; Tontonoz P
Elife; 2015 Mar; 4():. PubMed ID: 25806685
[TBL] [Abstract][Full Text] [Related]
19. LXRs regulate ER stress and inflammation through dynamic modulation of membrane phospholipid composition.
Rong X; Albert CJ; Hong C; Duerr MA; Chamberlain BT; Tarling EJ; Ito A; Gao J; Wang B; Edwards PA; Jung ME; Ford DA; Tontonoz P
Cell Metab; 2013 Nov; 18(5):685-97. PubMed ID: 24206663
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidylcholine acyltransferase 1 altered phospholipid composition and regulated hepatoma progression.
Morita Y; Sakaguchi T; Ikegami K; Goto-Inoue N; Hayasaka T; Hang VT; Tanaka H; Harada T; Shibasaki Y; Suzuki A; Fukumoto K; Inaba K; Murakami M; Setou M; Konno H
J Hepatol; 2013 Aug; 59(2):292-9. PubMed ID: 23567080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
